| 1. |
Lee SJ, Kim SH, Kim W, et al. Increased plasma osteopontin in frequent exacerbator and acute exacerbation of COPD. Clin Respir J, 2014; 8(3): 305-311.
|
| 2. |
Zanotti S, Gibertini S, Di Blasi C, et al. Osteopontin is highly expressed in severely dystrophic muscle and seems to play a role in muscle regeneration and fibrosis. Histopathology, 2011; 59(6): 1215-1228.
|
| 3. |
Courter D, Cao H, Kwok S, et al. The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways. PLoS One, 2010; 5(3): e9633.
|
| 4. |
Ito K, Kon S, Nakayama Y, et al. The differential amino acid requirement within osteopontin in alpha4 and alpha9 integrin-mediated cell binding and migration. Matrix Biol, 2009; 28(1): 11-19.
|
| 5. |
Klaning E, Christensen B, Bajic G, et al. Multiple low-affinity interactions support binding of human osteopontin to integrin alphaXbeta2. Biochim Biophys Acta 2015; 1854(8): 930-938.
|
| 6. |
Arjomandi M, Frelinger J, Donde A, et al. Secreted osteopontin is highly polymerized in human airways and fragmented in asthmatic airway secretions. PLoS One, 2011; 6(10): e25678.
|
| 7. |
Ramaiah SK. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol Sci, 2008; 103(1): 4-13.
|
| 8. |
Shi SM, Su ZB, Zhao JJ, et al. Increased osteopontin protein expression may be correlated with poor prognosis in non-small-cell lung cancer: a meta analysis. Cancer Res Ther, 2016; 12(1): 277-282.
|
| 9. |
Kanemitsu Y, Ito I, Niimi A, et al. Osteopontin and periostin are associated with a 20-year decline of pulmonary function in patients with asthma. Am J Respir Crit Care Med, 2014; 190(4): 472-474.
|
| 10. |
Samitas K, Zervas E, Vittorakis S, et al. Osteopontin expression and relation to disease severity inhuman asthma. Eur Respir J, 2011; 37(2): 331-341.
|
| 11. |
Hansel NN, Cheadle C, Diette GB, et al. Analysis of CD4+ T-cell gene expression in allergic subjects using two different microarray platforms. Allergy, 2008; 63(3): 366-369.
|
| 12. |
Xanthou G, Alissafi T, Semitekolou M, et al. Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med, 2007; 13(5): 570-578.
|
| 13. |
Kurokawa M, Konno S, Takahashi A, et al. Regulatory role of DC-derived osteopontin in systemic allergen sensitization. Eur J Immunol, 2009; 39(12): 3323-3330.
|
| 14. |
Hillas G, Loukides S, Kostikas K, et al. Increased levels of osteopontin in sputum supernatant of smoking asthmatics. Cytokine, 2013, 61(1): 251-255.
|
| 15. |
Gela A, Kasetty G, Mörgelin M, et al. Osteopontin binds and modulates functions of eosinophil-recruiting chemokines. Allergy, 2016, 71(1): 58-67.
|
| 16. |
Kohan M, Bader R, Puxeddu I, et al. Enhanced osteopontin expression in a murine model of allergen-induced airway remodelling. Clin Exp Allergy, 2007; 37(10): 1444-1454.
|
| 17. |
Kohan M, Breuer R. Osteopontin induces airway remodeling and lung fibroblast activation in a murine model of asthma. Am J Respir Cell Mol Biol, 2009; 41(3): 290-296.
|
| 18. |
Simoes DC, Xanthou G, Petrochilou K, et al. Osteopontin deficiency protects against airway remodeling and hyperresponsiveness in chronic asthma. Am J Respir Crit Care Med, 2009; 179(10): 894-902.
|
| 19. |
Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2017 report[EB/OL]. http://www.goldcopd.org.
|
| 20. |
Schneider DJ, Lindsay JC, Zhou Y, et al. Adenosine and osteopontin contribute to the development of chronic obstructive pulmonary disease. FASEB J, 2010; 24(1): 70-80.
|
| 21. |
Papaporfyriou A, Loukides S, Kostikas K, et al. Increased levels of osteopontin in sputum supernatant in patients with COPD. Chest, 2014; 146(4): 951-958.
|
| 22. |
Shan M, Yuan X, Song LZ, et al. Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema.Sci Transl Med, 2012; 4(117): 117ra9.
|
| 23. |
Gela A, Bhongir RK, Mori M, et al. Osteopontin That Is Elevated in the Airways during COPD Impairs the Antibacterial Activity of Common Innate Antibiotics. PLoS One, 2016; 11(1): e0146192.
|
| 24. |
Rosenberg M, Meyer FJ, Gruenig E, et al. Osteopontin (OPN) improves risk stratification in pulmonary hypertension (PH). Int J Cardiol, 2012; 155(3): 504-505.
|
| 25. |
Anwar A, Li M, Frid MG, et al. Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol, 2012; 303(1): L1-L11.
|
| 26. |
Saker M, Lipskaia L, Marcos E, et al. Osteopontin, a Key Mediator Expressed by Senescent Pulmonary Vascular Cells in Pulmonary Hypertension.Arterioscler Thromb Vasc Biol, 2016; 36(9): 1879-1890.
|
| 27. |
Zhang T, Zhang DM, Zhao D, et al. Osteopontin expression is associated with platinum-based chemotherapy response and prognosis of patients with advanced non small cell lung cancer. J BUON, 2014; 19(3): 742-748.
|
| 28. |
Chen RX, Xia YH, Xue TC. Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression. Mol Biol Rep, 2011; 38(6): 3671-3677.
|
| 29. |
Blasberg JD, Goparaju CM, Pass HI. Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity. J Thorac Cardiovasc Surg, 2010; 139(6): 1587-1593.
|
| 30. |
Kale S, Raja R, Thorat D, et al. Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin. Oncogene, 2014; 33(18): 2295-2306.
|
1/5
WeChat